Vivosim Lab Inc (VIVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,230 | -11,719 | -2,769 | -18,710 | -15,987 |
| Depreciation Amortization | 18 | 8 | 4 | 1,142 | 1,136 |
| Accounts receivable | 111 | 92 | 27 | 392 | 349 |
| Accounts payable and accrued liabilities | -309 | -519 | -610 | 92 | 194 |
| Other Working Capital | -2,285 | -3,071 | -724 | -998 | -108 |
| Other Operating Activity | 5,486 | 5,491 | 1,502 | 3,200 | 2,743 |
| Operating Cash Flow | $-11,209 | $-9,718 | $-2,570 | $-14,882 | $-11,673 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -282 | 7 | 2 | 747 | 728 |
| Investing Cash Flow | $-282 | $7 | $2 | $747 | $728 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,086 | 14 | N/A | 4,996 | 4,996 |
| Common Stock Repurchased | -1 | -1 | N/A | N/A | 0 |
| Other Financing Activity | -3 | -2 | -1 | -61 | -61 |
| Financing Cash Flow | $3,082 | $11 | $-1 | $4,935 | $4,935 |
| Beginning Cash Position | 27,356 | 27,356 | 27,356 | 36,556 | 36,556 |
| End Cash Position | 18,947 | 17,656 | 24,787 | 27,356 | 30,546 |
| Net Cash Flow | $-8,409 | $-9,700 | $-2,569 | $-9,200 | $-6,010 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,209 | -9,718 | -2,570 | -14,882 | -11,673 |
| Capital Expenditure | -294 | 0 | N/A | N/A | 0 |
| Free Cash Flow | -11,503 | -9,718 | -2,570 | -14,882 | -11,673 |